1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Veerhealth Care Limited

Veerhealth Care Limited

VEERHEALTH.BO
Veerhealth Care LimitedIN flagBombay Stock Exchange
37.21
INR
+3.26
- -
744.14MMarket Cap

Total Valuation

Veerhealth Care Limited carries a market capitalization of 744.14M, placing it among publicly traded companies globally. Its enterprise value stands at 440.65M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap744.14M
Enterprise Value440.65M

Share Statistics

Veerhealth Care Limited currently has 20.00M shares outstanding.

Shares Outstanding20.00M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Veerhealth Care Limited trades at a trailing price-to-earnings ratio of 73.45. The price-to-sales ratio is 1.23, and the price-to-book ratio stands at 2.00.

PE Ratio73.45
PS Ratio1.23
PB Ratio2.00
P/TBV Ratio1.74
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Veerhealth Care Limited trades at an EV/EBITDA multiple of 37.71 and an EV/FCF ratio of 253.36. The EV/Sales ratio of 1.36 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 37.71 provides insight into valuation relative to core operating earnings.

EV / Sales1.36
EV / EBITDA37.71
EV / EBIT37.71
EV / FCF253.36

Financial Position

Veerhealth Care Limited maintains a current ratio of 1.37, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 19.96, indicating elevated leverage, while an interest coverage ratio of 2.91 demonstrates limited ability to service its debt obligations.

Current Ratio1.37
Quick Ratio0.03
Debt / Equity19.96
Debt / EBITDA3.92
Interest Coverage2.91

Financial Efficiency

Veerhealth Care Limited posts a return on equity of 2.63 and a return on invested capital of 1.85.

Return on Equity (ROE)2.63
Return on Assets (ROA)1.40
Return on Invested Capital (ROIC)1.85
Return on Capital Employed (ROCE)2.82
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover7.01

Taxes

Over the trailing twelve months, Veerhealth Care Limited has paid 7.14M in income taxes, reflecting an effective tax rate of 56.76.

Income Tax7.14M
Effective Tax Rate56.76

Stock Price Statistics

Veerhealth Care Limited's stock has gained approximately 82.85012% over the past 52 weeks. The 50-day moving average sits at 25.35, while the 200-day moving average is 20.47.

Beta (5Y)N/A
52-Week Price Change82.85012%
50-Day Moving Average25.35
200-Day Moving Average20.47
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Veerhealth Care Limited generated 324.85M in revenue and converted that into 5.44M in net income, yielding earnings per share of 0.27. EBITDA reached 11.68M, while operating income came in at 11.68M.

Revenue324.85M
Gross Profit83.34M
Operating Income11.68M
Pretax Income12.58M
Net Income5.44M
EBITDA11.68M
EBIT11.68M
Earnings Per Share (EPS)0.27

Balance Sheet

Veerhealth Care Limited holds 4.58M in cash and equivalents against 45.75M in total debt, resulting in a net debt position of 41.17M. Total book value stands at 199.99M, with working capital of 50.30M providing operational flexibility.

Cash & Cash Equivalents4.58M
Total Debt45.75M
Net Debt41.17M
Equity (Book Value)199.99M
Book Value Per Share10.08
Working Capital50.30M

Margins

Veerhealth Care Limited operates with a gross margin of 25.66, reflecting its pricing power and cost economics. The operating margin of 3.60 and net profit margin of 1.67 provide insight into operational efficiency.

Gross Margin25.66
Operating Margin3.60
Pretax Margin3.87
Profit Margin1.67
EBITDA Margin3.60

Stock Splits

Veerhealth Care Limited's most recent stock split took place on September 22, 2023 with a 1:2 split ratio.

Last Split Date9/22/2023
Split Ratio1:2

Scores

Veerhealth Care Limited posts an Altman Z-Score of 2.09, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.09